Female Cancer Patients' Preference For Sexual Health Interventions

Breast Cancer Clinical Trial

Official title:

A Pilot Study Surveying Female Cancer Patients' Preference For Sexual Health Interventions

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01084642
• Other study ID #: 10-034
• Status: Completed
• Phase: N/A
• First received: March 9, 2010
• Last updated: July 5, 2017
• Start date: March 4, 2010
• Est. completion date: July 3, 2017

Study information

• Verified date: April 2017
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to survey female cancer patients' awareness of and preference for methods to improve sexual health. This information will help to improve our understanding of the needs and preferences for sexual health strategies and interventions of our female patients.

The findings of this survey will also be used to develop feasible sexual health resources for our patients and enhance the success of grant proposals to support future sexual health interventions at MSKCC.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 229
• Est. completion date: July 3, 2017
• Est. primary completion date: July 3, 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Participants must be able to communicate in English to complete the tests.

• Study group of breast and/or gynecological cancer survivors.

• History of Primary diagnosis of breast and/or gynecological cancer

• At least 21 years of age.

• In the judgement of the consenting professional able to provide informed consent

• In the judgement of the consenting professional, able to communicate well enough in English through verbal and written communication to complete the study assessments.

Exclusion Criteria:

• In the judgement of the consenting professional, the individual is able to provide informed consent.

• Patients with a psychiatric disorder precluding response to the surveys.

Related Conditions & MeSH terms

• Breast Cancer
• Gynecologic Cancer

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Participant' awareness of sexual health issues & preference for sexual health intervention		2 years
Secondary	To assess & describe female cancer patients' attitudes towards & preference of methods to receive sexual health information (verbal or written) & psychosexual education patient information cards or intervention modality (telephone, in-person or online).		2 years

External Links

•   Memorial Sloan Kettering Cancer Center